FDA Issues Warning Letter to AnuMed International
August 28, 2024
August 28, 2024
WASHINGTON, Aug. 28 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to AnuMed International LLC:
* * *
To: Julie R. Alcantar, Owner, AnuMed International, LLC, 3908 E Broadway Rd, Suite 110, Phoenix, AZ 85040-2995, United States, julie@anumed-intl.com
Dear Julie Alcantar:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, AnuMed Internation . . .
* * *
To: Julie R. Alcantar, Owner, AnuMed International, LLC, 3908 E Broadway Rd, Suite 110, Phoenix, AZ 85040-2995, United States, julie@anumed-intl.com
Dear Julie Alcantar:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, AnuMed Internation . . .